Assessment of Takayasu's arteritis activity by ultrasound localization microscopy.

Contrast-enhanced ultrasound Disease activity Microvessels Super-resolution imaging Takayasu arteritis

Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 13 09 2022
revised: 10 02 2023
accepted: 10 02 2023
medline: 18 4 2023
pubmed: 10 3 2023
entrez: 9 3 2023
Statut: ppublish

Résumé

Ultrasound localization microscopy (ULM) based on ultrafast ultrasound imaging of circulating microbubbles (MB) can image microvascular blood flows in vivo up to the micron scale. Takayasu arteritis (TA) has an increased vascularisation of the thickened arterial wall when active. We aimed to perform vasa vasorum ULM of the carotid wall and demonstrate that ULM can provide imaging markers to assess the TA activity. Patients with TA were consecutively included with assessment of activity by the National Institute of Health criteria: 5 had active TA (median age 35.8 [24.5-46.0] years) and 11 had quiescent TA (37.2 [31.7-47.3] years). ULM was performed using a 6.4 MHz probe and a dedicated imaging sequence (plane waves with 8 angles, frame rate 500 Hz), coupled with the intravenous injection of MB. Individual MB were localised at a subwavelength scale then tracked, allowing the reconstruction of the vasa vasorum flow anatomy and velocity. ULM allowed to show microvessels and to measure their flow velocity within the arterial wall. The number of MB detected per second in the wall was 121 [80-146] in active cases vs. 10 [6-15] in quiescent cases (p = 0.0005), with a mean velocity of 40.5 [39.0-42.9] mm.s ULM allows visualisation of microvessels within the thickened carotid wall in TA, with significantly greater MB density in active cases. ULM provides a precise visualisation in vivo of the vasa vasorum and gives access to the arterial wall vascularisation quantification. French Society of Cardiology. ART (Technological Research Accelerator) biomedical ultrasound program of INSERM, France.

Sections du résumé

BACKGROUND BACKGROUND
Ultrasound localization microscopy (ULM) based on ultrafast ultrasound imaging of circulating microbubbles (MB) can image microvascular blood flows in vivo up to the micron scale. Takayasu arteritis (TA) has an increased vascularisation of the thickened arterial wall when active. We aimed to perform vasa vasorum ULM of the carotid wall and demonstrate that ULM can provide imaging markers to assess the TA activity.
METHODS METHODS
Patients with TA were consecutively included with assessment of activity by the National Institute of Health criteria: 5 had active TA (median age 35.8 [24.5-46.0] years) and 11 had quiescent TA (37.2 [31.7-47.3] years). ULM was performed using a 6.4 MHz probe and a dedicated imaging sequence (plane waves with 8 angles, frame rate 500 Hz), coupled with the intravenous injection of MB. Individual MB were localised at a subwavelength scale then tracked, allowing the reconstruction of the vasa vasorum flow anatomy and velocity.
FINDINGS RESULTS
ULM allowed to show microvessels and to measure their flow velocity within the arterial wall. The number of MB detected per second in the wall was 121 [80-146] in active cases vs. 10 [6-15] in quiescent cases (p = 0.0005), with a mean velocity of 40.5 [39.0-42.9] mm.s
INTERPRETATION CONCLUSIONS
ULM allows visualisation of microvessels within the thickened carotid wall in TA, with significantly greater MB density in active cases. ULM provides a precise visualisation in vivo of the vasa vasorum and gives access to the arterial wall vascularisation quantification.
FUNDING BACKGROUND
French Society of Cardiology. ART (Technological Research Accelerator) biomedical ultrasound program of INSERM, France.

Identifiants

pubmed: 36893585
pii: S2352-3964(23)00067-1
doi: 10.1016/j.ebiom.2023.104502
pmc: PMC10017361
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104502

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests All authors have no conflicts of interest to disclose.

Auteurs

Guillaume Goudot (G)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France; Université Paris Cité, INSERM U970 PARCC, F-75015 Paris, France. Electronic address: guillaume.goudot@aphp.fr.

Anatole Jimenez (A)

Physics for Medicine Paris, INSERM U1273, ESPCI Paris, CNRS UMR 8631, PSL Research University, Paris, France.

Nassim Mohamedi (N)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France; Université Paris Cité, INSERM U970 PARCC, F-75015 Paris, France.

Jonas Sitruk (J)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France; Université Paris Cité, INSERM U970 PARCC, F-75015 Paris, France.

Lina Khider (L)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France; Université Paris Cité, INSERM U970 PARCC, F-75015 Paris, France.

Hélène Mortelette (H)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Clément Papadacci (C)

Physics for Medicine Paris, INSERM U1273, ESPCI Paris, CNRS UMR 8631, PSL Research University, Paris, France.

Fabien Hyafil (F)

Nuclear Medicine Department, Georges Pompidou European Hospital, APHP, Université Paris Cité, Paris, France.

Mickaël Tanter (M)

Physics for Medicine Paris, INSERM U1273, ESPCI Paris, CNRS UMR 8631, PSL Research University, Paris, France.

Emmanuel Messas (E)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France; Université Paris Cité, INSERM U970 PARCC, F-75015 Paris, France.

Mathieu Pernot (M)

Physics for Medicine Paris, INSERM U1273, ESPCI Paris, CNRS UMR 8631, PSL Research University, Paris, France.

Tristan Mirault (T)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France; Université Paris Cité, INSERM U970 PARCC, F-75015 Paris, France; French National Reference Centre for Rare Vascular Diseases, FAVA-MULTI, Member of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), F-75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH